More on ADAG
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $3.17 |
|
|||
| Open | $3.30 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $3.42 | ||||
| Day Low | $3.17 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 260,360 | ||||
- Form 4 Adagene Inc. For: Sep 16 Filed by: Luo Peter
- H.C. Wainwright Reiterates Buy Rating on Adagene Inc (ADAG)
- Third Arc Bio picks lead candidate in amended Adagene collaboration
- Form 6-K Adagene Inc. For: Sep 10
- Adagene Announces that Third Arc Bio Has Selected First Lead Candidate under Amended Strategic Collaboration for Development of Masked CD3 T Cell Engagers Utilizing SAFEbody® Technology
- Chardan Starts Adagene Inc (ADAG) at Buy
- Adagene Achieves Milestone in Collaboration with Exelixis for Advancement of SAFEbody® Antibody-Drug Conjugate Candidates
- Form 144/A Adagene Inc. Filed by: GU CHUNFANG
- Adagene to Participate in Three Upcoming Investor Conferences
- Form 144 Adagene Inc. Filed by: GU CHUNFANG
Entities mentioned with ADAG
- Vanguard | View Related Stories »
- Twitter | View Related Stories »
- FDA | View Related Stories »
- Earnings | View Related Stories »
- 13G | View Related Stories »
- Jefferies & Co | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Show More...
